Myeloma Patients Who Relapse After CAR T-Cell Therapy Have Options

(MedPage Today) -- Patients with multiple myeloma who relapse after treatment with B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy can be salvaged with multiple lines of therapy, a retrospective study suggested...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news